When everyone is bullish, perhaps you should be cautious. When everyone is bearish, maybe you should be bold.
For each of the following three ultra-popular stocks, the lowest price target from an analyst on Wall Street implies downside ranging from 50% to as much as 97%! First up is one of the absolute hottest stocks since the end of 2019, biotech stock Moderna (NASDAQ: MRNA). Taking into account Moderna's insane run over the past two weeks, shares are up almost 1,700% since the end of 2019.
Yahoo Finance's Emily McCormick joined Yahoo Finance Live to break down the key takeaways from PayPal's recent earnings report.
Ford's electric truck ambitions appear to be gaining steam.
(Bloomberg) -- China’s largest private education firms are moving swiftly to overhaul their businesses to adjust to a harsh new reality after Beijing launched a sweeping crackdown on the $100 billion sector.Two of the sector’s biggest names have in past days reached out to reassure investors and managers their businesses remain viable and won’t abruptly collapse, according to people familiar with the matter. Yuanfudao, the $15.5 billion startup backed by Tencent Holdings Ltd. and DST Global, pla
The stocks of companies focused on alternative energy development -- and the hydrogen economy in particular -- jumped today, bringing them back into the black for the week. Specifically, as of 3:45 p.m. EDT, shares of electric vehicle maker Nikola (NASDAQ: NKLA) bounced 7.7%, Plug Power (NASDAQ: PLUG) stock was up 5.4%, and Bloom Energy (NYSE: BE) shares jumped 6.75%.
Yahoo Finance's Dan Howley breaks down Qualcomm's Q3 earnings report.
In the race to develop COVID-19 vaccines, Novavax (NASDAQ: NVAX) seems to have gotten the most important part right. The latest clinical trial data for the NVX-CoV2373 vaccine showed 90% overall efficacy against early variants after demonstrating 96% efficacy against the original strain. Novavax is expected to file for Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) in September, after which more data should be forthcoming.
According to the Wall Street Journal, AMC's multi-bagger rally was driven by retail speculation and an intentional short squeeze. AMC has reopened almost all its U.S. locations. In July, Disney (NYSE: DIS) released Black Widow, the first Marvel movie to hit theaters since the pandemic.
Cleveland Cliffs extended gains from its reversal last week crossing above an area of resistance around 23.45. A lot of earnings on tap among miners.
HELSINKI/STOCKHOLM (Reuters) -Nokia on Thursday raised its full-year outlook after reporting a stronger-than-expected second-quarter operating profit, as the telecom equipment maker benefits from a sharp turnaround in its business. A round of changes in the company's operations, greater investment on research and a geopolitical situation tilting in its favour has put Nokia firmly back in the global 5G rollout race just a year after CEO Pekka Lundmark took the reins, allowing it to gain ground on Swedish arch-rival Ericsson. "Our 5G position has clearly strengthened ... we are winning back customers," Lundmark said on a call, confirming a rosier outlook first signalled in February.
Elon Musk earlier this week made his most bullish statements yet on iron-based batteries, noting that Tesla is making a “long-term shift” toward older, cheaper lithium-iron-phosphate (LFP) cells in its energy storage products and some entry-level EVs. The Tesla CEO mused that the company's batteries may eventually be roughly two-thirds iron-based and one-third nickel-based across its products. Musk's comments reflect a change that is already underway within the automotive sector, mainly in China.
In this article, we will discuss the 11 best pharma and biotech stocks to buy according to Jim Simons’ Euclidean Capital. If you want to skip our detailed analysis of Simons’ history, investment philosophy, and hedge fund performance, go directly to the 5 Best Pharma and Biotech Stocks to Buy According to Jim Simons’ Euclidean […]
BRUSSELS (Reuters) -Anheuser-Busch InBev underwhelmed on second-quarter profit on Thursday as costs increased even though the world's largest brewer drove revenues to above pre-pandemic levels. The brewer reported lower core profits in its two biggest markets, the United States and Brazil, as cans and distribution became more expensive and a weaker Brazilian real bit. AB InBev retained its forecast that earnings before interest, tax, depreciation and amortisation (EBITDA) would grow by between 8% and 12% this year, with revenue increasing at a faster pace.
The odds were stacked against Intel (NASDAQ: INTC) going into its second-quarter earnings report. One might think a performance like that would have been just what Intel shareholders wanted to see after the company started the year on a disappointing note. Intel's revenue increased 2% year over year in Q2 to $18.5 billion while adjusted earnings per share jumped 12% to $1.28 per share.
Buybacks come around a year after the company took the leap of cutting its dividend.
What happened Wednesday is shaping up to be a profitable day for cannabis investors. Here's how some of the most popular pot stocks were performing as of 12:30 p.m. EDT today: Sundial Growers (NASDAQ: SNDL), up 10% OrganiGram Holdings (NASDAQ: OGI), up 9% Aurora Cannabis (NASDAQ: ACB), up 8% Canopy Growth (NASDAQ: CGC), up 7% Hexo (NYSE: HEXO), up 7% So what The gains were sparked by a blockbuster earnings report from industry heavyweight Tilray (NASDAQ: TLRY).
(Bloomberg) -- Royal Dutch Shell Plc raised its dividend by almost 40% and said it will buy back $2 billion of shares, continuing an effort to win back investors as stronger oil prices and a buoyant chemicals market lifted earnings.The move comes more than a year after Shell slashed its dividend by two-thirds. Modest increases to the payout since then did little to boost the company’s appeal, with its shares still about 40% lower than pre-pandemic levels despite a full recovery in oil prices.The
If you qualify, you'll receive a direct deposit or paper check automatically.
(Bloomberg) -- Didi Global Inc. surged after the Wall Street Journal reported the firm is considering going private to placate Chinese regulators and compensate investors for losses.The Beijing-based company has been in discussions with bankers, regulators and key investors about ways to resolve regulatory woes since its troubled listing, the newspaper said, citing people with knowledge of the matter. One of the options could involve a tender offer for the publicly traded shares, according to th
Aurora Cannabis (NASDAQ: ACB) has long been an underperforming marijuana stock. There's definitely risk involved here, but investors have seen just how quickly the stock can rise on some bullishness; shares of Aurora skyrocketed to highs of nearly $19 in February amid the meme hype. Should contrarian investors consider picking up the stock before the company announces its year-end results in September?